SWTX
SpringWorks Therapeutics
SWTX
SWTX
Delisted
SWTX was delisted on the 30th of June, 2025.
226 hedge funds and large institutions have $2.59B invested in SpringWorks Therapeutics in 2024 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 90 increasing their positions, 62 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $2.91B → $2.59B (-$318M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
51% less call options, than puts
Call options by funds: $4.46M | Put options by funds: $9.02M
Holders
226
Holding in Top 10
4
Calls
$4.46M
Puts
$9.02M
Top Buyers
| 1 | +$39.3M | |
| 2 | +$35.6M | |
| 3 | +$16M | |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
+$14.9M |
| 5 |
CCM
Cutter Capital Management
New York
|
+$12.1M |
Top Sellers
| 1 | -$49.5M | |
| 2 | -$32.2M | |
| 3 | -$30.8M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$11.9M |
| 5 |
O
OrbiMed
New York
|
-$10.1M |